相关实验视频

Updated: Aug 16, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.9K

基线葡萄糖与淋巴细胞的比率预测了nivolumab在晚期非小细胞肺癌中的结果:一个多中心的回顾性研究

Mustafa Ersoy1, Umut Kefeli2, Devrim Cabuk2

  • 1Department of Internal Medicine, Division of Medical Oncology, Kutahya Health Sciences University, Kutahya, Türkiye.

Frontiers in immunology
|March 2, 2026
PubMed
概括

葡萄糖与淋巴细胞比率 (GLR) 可以预测接受PD-1封锁的非小细胞肺癌 (NSCLC) 患者的生存率. 较低的GLR表明尼沃卢马布治疗NSCLC患者的整体存活率 (OS) 和无进展存活率 (PFS) 更好.

关键词:
生物标志物 生物标志物葡萄糖与淋巴细胞的比例.免疫检查点抑制剂 免疫检查点抑制剂免疫代谢的免疫代谢.这就是尼沃卢马布 (nivolumab).非小细胞肺癌的肺癌.预后 预后 预后幸存率 幸存率 生存率

更多相关视频

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.2K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.